The estimated Gilgamesh Pharmaceuticals valuation is $600.0M. This Gilgamesh Pharmaceuticals valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: Andrew Kruegel net worth, Dalibor Sames net worth, and JONATHAN SPORN net worth.
Search this company in the directory
The estimated Gilgamesh Pharmaceuticals valuation is $600.0M. This Gilgamesh Pharmaceuticals valuation is an independent model output, not a verified appraisal, official mark, or financial advice.
Gilgamesh Pharmaceuticals raised $60.0M in disclosed funding. How much Gilgamesh Pharmaceuticals raised informs the estimated Gilgamesh Pharmaceuticals valuation on this hub. Independent estimate only — not a complete financing history or financial advice.
Andrew Kruegel, Dalibor Sames, and JONATHAN SPORN founded Gilgamesh Pharmaceuticals. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.